GargSK, LiljenquistD, BodeB, et al.Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable eversense continuous glucose monitoring system: The PROMISE Study. Diabetes Technol Ther, 2022; 24(2):84–92.
2.
GargSK, KipnesM, CastorinoK, et al.Accuracy and safety of Dexcom G7 Continuous Glucose Monitoring in adults with diabetes. Diabetes Technol Ther, 2022; 24(6):373–380; doi: 10.1089/dia.2022.0011
HirschIB.Introduction: History of Glucose Monitoring. In Role of Continuous Glucose Monitoring in Diabetes Treatment. American Diabetes Association: Arlington County, VA; ADA Clin Comp, 2018; 2018(1):1; doi: 10.2337/db20181-1
5.
KovatchevBP, PatekSD, OrtizEA, et al.Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther, 2015; 17(3):177–186.
6.
El MalahiA, Van ElsenM, CharleerS, et al.Relationship between time in range, glycemic variability, HbA1c, and complications in adults with type 1 diabetes mellitus. J Clin Endocrinol Metab, 2022; 107(2):e570–e581.
7.
BattelinoT, AlexanderCM, AmielSA, et al.Continuous glucose monitoring and metrics for clinical trials: An international consensus statement. Lancet Diabetes Endocrinol, 2023; 11(1):42–57; doi: 10.1016/S2213-8587(22)00319-9
8.
TrivelliLA, RanneyHM, LaiHT. Hemoglobin components in patients with diabetes mellitus. New Engl J Med, 1971; 284:353–357.
9.
CerielloA, PrattichizzoF, PhillipM, et al.Glycaemic management in diabetes: Old and new approaches. Lancet Diabetes Endocrinol, 2022; 10(1):75–84; doi: 10.1016/S2213-8587(21)00245-X
